Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Update on Status of Rivaroxaban Complete Response Letter From U.S. FDA
BayNews International, 07/15/09
Bayer Schering Pharma AG, Germany, announced that its partner, Ortho-McNeil, does not expect to submit its complete response to the U.S. Food and Drug Administration (FDA) until the fourth quarter of this year, at the earliest.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09
Article Search
Sponsor


See Latest Articles


